Cleared Traditional

K171323 - BIOPHOTAS CELLUMA3 (FDA 510(k) Clearance)

Class II General & Plastic Surgery device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K171323 · Biophotas, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2017
Decision
119d
Days
Class 2
Risk

K171323 is an FDA 510(k) clearance for the BIOPHOTAS CELLUMA3. Classified as Light Based Over The Counter Wrinkle Reduction (product code OHS), Class II - Special Controls.

Submitted by Biophotas, Inc. (Anaheim, US). The FDA issued a Cleared decision on September 1, 2017 after a review of 119 days - within the typical 510(k) review window.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Biophotas, Inc. devices

Submission Details

510(k) Number K171323 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 05, 2017
Decision Date September 01, 2017
Days to Decision 119 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
5d slower than avg
Panel avg: 114d · This submission: 119d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OHS Light Based Over The Counter Wrinkle Reduction
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition Use Of Light Based Treatment To Reduce Wrinkles On The Body In General Or Specific Anatomical Locations Depending On The Information Provided.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - OHS Light Based Over The Counter Wrinkle Reduction

All 148
Devices cleared under the same product code (OHS) and FDA review panel - the closest regulatory comparables to K171323.
LED FACIAL MASK (MJ-66DB, MK-99, MK-99A, MK-99M, MJ-66C)
K260150 · NOOANCE · Apr 2026
LED Light Therapy Masks (LumiLips FAC07NA)
K260202 · Guangdong Newdermo Biotech Co., Ltd. · Mar 2026
LED Light Therapy Mask (Models: T2, RLD10)
K254079 · Shenzhen Desida Technology Co., Ltd. · Mar 2026
Ulike Reglow Light Therapy Device (UM10)
K260511 · Shenzhen Ulike Smart Electronics Co., Ltd. · Mar 2026
LED Therapy Light (COB1400, HP1800PRO)
K253874 · Shenzhen Hanhua Opto Co., Ltd. · Mar 2026
FAQ™ (LED Panel)
K253683 · Foreo, Inc. · Feb 2026